Home > Mint Authors > C H Unnikrishnan

C H Unnikrishnan

Mint Author

ARTICLES BY C H UNNIKRISHNAN

Piramal Group chairman Ajay Piramal. Photo: Hemant Mishra/Mint

Piramal, Navin Fluorine forms JV to manufacture fluorochemicals

1 min read . 27 Aug 2014

Sanofi’s overall expenses stood at `387.9 crore in the quarter. Photo: Mint

Sanofi India posts 16.44% increase in net profit

1 min read . 30 Apr 2014

The industry has overcome the hurdles in mid-2013 following the implementation of drug price control order and it has showed strong resilience and recovery in the last three months, posting a growth of 12.2%. Photo: Mint

Indian pharma sales up 11.3% in January

1 min read . 15 Feb 2014

Aurobindo plans to fund the acquisition through internal accruals. Photo: Mint

Aurobindo to buy Actavis’s loss making European business

2 min read . 19 Jan 2014

A screen grab of Uniphos Envirotronic Pvt Ltd website.

Uniphos acquires gas detection tube business of MSA-Germany

1 min read . 11 Jan 2014

The unexpected import ban on the Mohali facility sent shares in Ranbaxy plunging by one-third on Monday. Photo: Pradeep Gaur/Mint (Pradeep Gaur/Mint)

Suspected hair in pill may have sparked FDA’s Ranbaxy import ban

2 min read . 18 Sep 2013

Sales in India grew 16.7% to `1,132 crore in the June quarter.

Cipla Q1 net up 18.5% to `475 crore

1 min read . 09 Aug 2013

A file photo of Glenmark Pharma’s Ankleshwar Plant in Gujarat (A file photo of Glenmark Pharma’s Ankleshwar Plant in Gujarat)

Glenmark posts 64% rise in Q1 net

1 min read . 01 Aug 2013

The company’s drug formulation exports during the December quarter grew 38% to `969 crore, and the domestic business expanded 10.2% to `957 crore. Photo: Ramesh Pathania/Mint (Ramesh Pathania/Mint)

Cipla Q3 net up 26% on export growth; Y.K. Hamied to retire as MD

1 min read . 06 Feb 2013

An aggressive plan to enhance operational efficiency through a new product mix and cost savings has had a positive impact on the industry’s margins, according to analysts. Photo: Ramesh Pathania/Mint (Ramesh Pathania/Mint)

Pharma companies register rise in sales

3 min read . 29 Jan 2013

Analysts had estimated that Glenmark will report profit in the range of `170-180 crore on revenue of about `1,250 crore for the quarter. Photo: Pradeep Gaur/Mint (Pradeep Gaur/Mint)

Glenmark beats market expectation with fivefold growth in net profit

1 min read . 29 Jan 2013

Cipla can supply the new malaria drug to other markets under WHO’s anti-malaria programmes and also independently. (Cipla can supply the new malaria drug to other markets under WHO’s anti-malaria programmes and also independently.)

Cipla’s new malaria drug gets WHO nod

1 min read . 03 Oct 2012

GSK India April-June profit up 9%

1 min read . 10 Aug 2011

RPG Life inks long term API partnership with Polpharma

1 min read . 21 Oct 2010

×

Get alerts on WhatsApp

Set Preferences My Reads Watchlist Feedback Redeem a Gift Card Logout